View Older Stories View More Recent Stories

Mar 27, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)

Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'

Mar 16, 2025 10:00AM Will Pfizer step into the obesity ring? Wolfe Research answers

Mar 11, 2025 07:03AM Viking Therapeutics (VKTX) Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

Mar 11, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)

Feb 21, 2025 12:29PM Viking Therapeutics (VKTX) Strength Said to be Tied to Unconfirmed M&A Chatter

Feb 7, 2025 06:52AM Citi Starts Viking Therapeutic (VKTX) at Neutral

Feb 6, 2025 12:07PM Viking Therapeutic (VKTX) PT Lowered to $95 at Truist Securities

Feb 6, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)

Feb 5, 2025 04:13PM Viking Therapeutics (VKTX) Misses Q4 EPS by 4c

Feb 5, 2025 10:46AM Viking Therapeutics (VKTX) call put ratio 16 calls to 1 put with a focus on February 7 weekly calls into quarter results

Feb 4, 2025 10:21AM Viking Therapeutics (VKTX) ticks higher on industry chatter

Jan 23, 2025 05:17AM Viking Therapeutics (VKTX) call put ratio 6.3 calls to 1 put with a focus on January 24 weekly calls

Jan 21, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)

Jan 15, 2025 04:52AM Viking Therapeutics (VKTX) call put ratio 1.3 calls to 1 put as share price trends lower

Jan 9, 2025 10:28AM Truist Securities Reiterates Buy Rating on Viking Therapeutic (VKTX) 'As Competitor Data Disappoint'

Jan 8, 2025 07:03AM Viking Therapeutics (VKTX) Initiates Phase 2 VENTURE-Oral Dosing Trial of VK2735

Dec 20, 2024 07:13AM Viking Therapeutics (VKTX), Others Gain After Novo Nordisk (NVO) Data Falls Short of Expectations

Dec 18, 2024 03:21PM Viking Therapeutics (VKTX) call put ratio 2. Calls to 1 put with focus on February calls

Dec 18, 2024 07:51AM Viking Therapeutics (VKTX) weakness tied to Merck's (MRK) Deal for GLP-1 Receptor Agonist

Dec 2, 2024 04:10AM Piper Sandler Starts Viking Therapeutic (VKTX) at Overweight

Nov 26, 2024 01:17PM BTIG Reiterates Viking Therapeutic (VKTX) at Buy, 'continue to see sub-q VK2735 remaining highly competitive'

Nov 22, 2024 02:25AM B.Riley Starts Viking Therapeutic (VKTX) at Buy

Nov 19, 2024 05:04PM After-hours movers: Dolby Laboratories, Powell Industries, Keysight Technologies

Nov 19, 2024 04:03PM Viking Therapeutics (VKTX) Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting

Nov 4, 2024 10:50AM Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)

Nov 4, 2024 06:30AM Viking Therapeutics (VKTX) Reports New Data from VK2735 Obesity Program

Nov 4, 2024 06:19AM Jefferies Reiterates Buy Rating on Viking Therapeutic (VKTX)

Oct 24, 2024 05:42AM BTIG Reiterates Buy Rating on Viking Therapeutic (VKTX)

Oct 23, 2024 04:15PM Viking Therapeutics (VKTX) Tops Q3 EPS by 2c

Oct 22, 2024 11:18AM Viking Therapeutics (VKTX) October 25 weekly option implied volatility bid into quarter results

Oct 17, 2024 06:12AM Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)

Oct 10, 2024 06:55AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)

Oct 9, 2024 07:01AM Viking Therapeutics (VKTX) Reports Results from Phase 1b Clinical Trial of VK0214

Oct 8, 2024 05:45AM Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)

Sep 30, 2024 06:03AM Morgan Stanley Reiterates Overweight Rating on Viking Therapeutic (VKTX)

Sep 25, 2024 12:31PM Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)

Sep 24, 2024 04:47AM Viking Therapeutics (VKTX) call put ratio 1.8 calls to 1 put with focus on October 70 calls.

Sep 20, 2024 11:05AM Viking Therapeutics (VKTX) call put ratio 12.1 calls to 1 put with focus on September 70 and 71 calls

Sep 20, 2024 09:31AM Novo Nordisk shares fall after Monlunabant phase 2a trial results; Viking jumps

Sep 20, 2024 08:56AM Viking Therapeutics (VKTX) ticks higher after Novo Nordisk's monlunabant obesity data

Sep 19, 2024 05:54AM Viking Therapeutics (VKTX) call put ratio 2.8 calls to 1 put with focus on September 28 calls

Sep 12, 2024 06:56AM Morgan Stanley Reiterates Overweight Rating on Viking Therapeutic (VKTX)

Sep 11, 2024 02:43AM JPMorgan Starts Viking Therapeutic (VKTX) at Overweight

Aug 27, 2024 01:37PM Truist Defending Viking Therapeutics (VKTX): 'recommend investors take advantage of today’s selloff to add to shares'

Aug 27, 2024 10:09AM Viking Therapeutics (VKTX) call put ratio 10.4 calls to 1 put after Eli Lilly & Co. (LLY) launches single-dose vials of Zepbound

Aug 20, 2024 02:16PM Viking Therapeutics (VKTX) September 80 and 90 calls active as share price down 5.4%

Aug 20, 2024 11:26AM Viking Therapeutics (VKTX) September 80 and 90 calls as share price down 6%

Aug 20, 2024 05:43AM Viking Therapeutics (VKTX) call put ratio 6.3 calls to 1 put with focus on September calls

Aug 19, 2024 03:39PM Viking Therapeutics (VKTX) Extends Gain, Climbs 17%

View More Recent Stories View Older Stories